Relationship between prorenin, IGF-I, IGF-binding proteins and retinopathy in diabetic patients

Abstract

Plasma prorenin and renin, serum insulin-like growth factor I (IGF-I) and IGF-binding protein (IGFBP-2 and IGFBP-3) concentrations were measured in 22 randomly selected male and female patients with insulin-dependent diabetes mellitus (IDDM) or non-IDDM (NIDDM). Plasma prorenin concentration was significantly elevated in patients with proliferative retinopathy (1869.5±785.0 mUL −1, mean±SEM) compared to patients with nonproliferative retinopathy (325.5±73.2 mUL −1, P<0.003) and those without retinopathy (318.6±47.3 mUL −1, P<0.007). Similarly, serum insulin-like growth factor-I (IGF-I) concentration in patients with proliferative retinopathy (216.3±21.5 μgL −1) was significantly higher than in patients with nonproliferative retinopathy (126.3±14.85 μgL −1, P<0.004) and without retinopathy (135.2±37.26, P<0.05). There was moderately strong positive correlation between plasma prorenin and serum IGF-I concentrations ( r=0.56, P<0.01). Plasma prorenin concentration was uninfluenced by change in renal function (creatinine clearance, serum creatinine or BUN), but IGF-I levels were inversely related to creatinine clearance ( r=0.67, P<0.002). There was no demonstrable relationship between IGF-binding proteins and prorenin or renin concentrations. In view of some overlap between plasma prorenin and serum IGF-I concentrations in diabetic patients with proliferative and nonproliferative retinopathy, measurement of both markers may be more useful in prédicting the development of proliferative retinopathy in patients with diabetes mellitus than either measurement alone.